Brief: Blue Water Biotech Announces Preclinical Data Supporting Immunogenicity Of Novel Monkeypox Vaccine

Onconetix

28/06/2023 13:00

June 28 (Reuters) - Blue Water Biotech Inc  BWV.O :
    * BLUE WATER BIOTECH ANNOUNCES PRECLINICAL DATA SUPPORTING
IMMUNOGENICITY OF NOVEL MONKEYPOX VACCINE UTILIZING NOROVIRUS
VIRUS-LIKE PARTICLE PLATFORM
    * BLUE WATER BIOTECH-INITIAL DATA SHOW MICE WERE ABLE TO
GENERATE
IMMUNE RESPONSE AFTER VACCINATION, ANTIBODIES WERE ABLE TO
NEUTRALIZE VACCINIA VIRUS

Source text for Eikon:  ID:nGNX26Ncc 
Further company coverage:  BWV.O 

 ((Reuters.Briefs@thomsonreuters.com;))